Overview
This observational study aims to construct and validate the performance of a multimodal predictive model in forecasting the outcomes of neoadjuvant therapy in patients with NSCLC.
The core research question is: Can a multi-model approach predict outcomes of neoadjuvant therapy for non-small cell lung cancer and provide clinical recommendations?
Eligibility
Inclusion Criteria:
- pathologically diagnosed non-small cell lung cancer
- The treatment plan is:receiving neoadjuvant chemo-immunotherapy during the study period, followed by surgical resection
Exclusion Criteria:
- recurrent or metastatic lung cancer;
- patients with other primary tumors